Right Decisions
TAM (Treatments and Medicines) NHS Highland
FORMULARIES
HIGHLAND FORMULARY
Back
DERMATOLOGY
Skin cleansers and antiseptics (Formulary)

Please update your RDS mobile app to version 4.7.1

We are pleased to advise that deep linking capability, enabling users to directly download individual mobile toolkits, has now been released on the RDS mobile app. When you install the update, you will see that each toolkit has a small QR code icon the header area beside the search icon – see screenshot below. Clicking on this icon will open up a window with a full-size QR code and the alternative of a short URL for sharing with users. Instructions are provided.

You may need to actively install the update to install RDS app version 4.7.1 to see this improvement. Installing this update is also strongly recommended to get the full benefits of the new contingency arrangements – specifically, that if the RDS website should fail, you will still be able to download new mobile app toolkits.

To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number. To install latest updates:

On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.

On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.

Please get in touch with ann.wales3@nhs.scot with any questions.

Skin cleansers and antiseptics (Formulary)

TAM (Treatments and Medicines) NHS Highland

For information on the use of skin cleansers and antiseptics refer to the NHS Scotland National Infection Prevention and Control Manual, the MRSA Policy and other Infection Control Policies. Also refer to emollients for hand eczema and emollient bath additives with antiseptics listed in Emollient and barrier preparations.

POTASSIUM PERMANGANATE

Important: Therapy notes

NPSA alert re inadvertent oral administration

Important: Formulation and dosage details

Formulation:

Tablets for cutaneous solution 400mg

Dosage:

BAD (British Association of Dermatology guidance recommendations: https://cdn.bad.org.uk/uploads/2022/05/04163130/Guidance-for-safe-use-of-potassium-permanganate-soaks-FINAL-for-website.pdf

Notes:

In primary care:

ensure patients are not on repeat prescriptions for potassium permanganate
prescriptions to include clear instructions to dilute before use
dispensing label to include the warning ‘HARMFUL IF SWALLOWED’.

In secondary care:

to be supplied on a named patient basis only
to be prescribed as ‘potassium permanganate 0.01% topical solution’ and the dispensing label must include the warning ‘HARMFUL IF SWALLOWED’
potassium permanganate is not to be stored with medicines for oral/internal use, including the ward drug trolley; dilution should occur away from the patient, and neither the concentrated form or the diluted form, should be left near the patient.

All settings:

prescriptions are only to be issued by an appropriate prescriber – see BAD recommendations
if potassium permanganate is to be used in a patient’s home, a risk assessment must be undertaken before prescribing
all patients must be supplied with a patient information leaflet: https://cdn.bad.org.uk/uploads/2021/12/28095034/Potassium-Permanganate-Solution-Soaks-Apr-2022.pdf